Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03131661
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
DRQ | (9ALPHA,13BETA,17BETA)-2-[(1Z)- BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE- 3,17-DIOL | A,B | 2G5O | 0.73 | |
DM4 | 1-O-DEMETHYL-6-DEOXYDOXORUBICIN | A | 1D37 | 0.74 | |
NCZ | 2-HYDROXY-7-METHOXY-5-METHYL-NAPHTHALENE- 1-CARBOXYLIC ACID MESO-2,5-DIHYDROXY- CYCLOPENT-3-ENYL ESTER | A | 1J5I | 0.74 | |
ESM | 1,3,5(10)-ESTRATRIEN-2,3,17-BETA- TRIOL 2-METHYL ETHER | A | 1LHW | 0.71 | |
MAR | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1D36 | 0.71 | |
MAR | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1R68 | 0.71 | |
MAR | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1D35 | 0.71 | |
ESL | ESTRIOL | A | 1X8V | 0.76 | |
DRA | 11-DEOXY-BETA-RHODOMYCIN | A,B | 1XDS | 0.73 | |
E3G | ESTRONE BETA-D-GLUCURONIDE | H,L | 1CFV | 0.91 | |
E3O | (16ALPHA,17ALPHA)-ESTRA-1,3,5(10)- TRIENE-3,16,17-TRIOL | A | 2J7Y | 0.76 | |
AKV | {3-[(1R,3S)-1,3-DIHYDROXYPENTYL]- 4,5,9,10-TETRAHYDROXY-2-ANTHRYL}ACETATE | A,B,C,D | 2F99 | 0.75 | |
EQU | EQUILENIN | A,B | 1OGX | 0.72 | |
EQU | EQUILENIN | A,B,C,D,E,F | 1QJG | 0.72 | |
EQU | EQUILENIN | A,B | 1OH0 | 0.72 | |
EQU | EQUILENIN | A | 1W6Y | 0.72 | |
EQU | EQUILENIN | A,B | 1CQS | 0.72 | |
EQU | EQUILENIN | A | 1OGZ | 0.72 | |
EQU | EQUILENIN | A | 1GS3 | 0.72 | |
EQU | EQUILENIN | A | 1OHO | 0.72 | |
DXA | 1,2-HYDRO-1-OXY-3,4-HYDRO-3-(1- METHOXY-2-OXY-3,4-DIHYDROXYPENTYL)- 8,9-DIHYDROXY-7-(SEC-BUTYL)-ANTHRACENE | A,B | 1CP8 | 0.73 | |
459 | 4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)- 8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON- 7-EN-2-YL]PHENOL | A,B | 2FAI | 0.7 | |
EST | ESTRADIOL | A,B | 1GWR | 0.74 | |
EST | ESTRADIOL | A | 1FDS | 0.74 | |
EST | ESTRADIOL | A,B,C | 1G50 | 0.74 | |
EST | ESTRADIOL | A,B,C,D,E,F | 1ERE | 0.74 | |
EST | ESTRADIOL | A,B | 1A52 | 0.74 | |
EST | ESTRADIOL | A | 1FDT | 0.74 | |
EST | ESTRADIOL | A | 2OCF | 0.74 | |
EST | ESTRADIOL | A,B,C | 1QKU | 0.74 | |
EST | ESTRADIOL | A,B,C,D,L | 1E6W | 0.74 | |
EST | ESTRADIOL | A | 1IOL | 0.74 | |
EST | ESTRADIOL | H | 1JNN | 0.74 | |
EST | ESTRADIOL | B | 1QKT | 0.74 | |
EST | ESTRADIOL | A | 1FDW | 0.74 | |
EST | ESTRADIOL | A,B | 1AQU | 0.74 | |
EST | ESTRADIOL | A | 1LHU | 0.74 | |
EST | ESTRADIOL | A | 1A27 | 0.74 | |
EST | ESTRADIOL | L | 1JGL | 0.74 | |
EST | ESTRADIOL | A,B,E,F | 1PCG | 0.74 | |
EST | ESTRADIOL | A,B,C,D | 1FDU | 0.74 | |
EST | ESTRADIOL | A | 2J7X | 0.74 | |
EST | ESTRADIOL | A,B | 2D06 | 0.74 | |
EQI | EQUILIN | A,B | 1EQU | 0.72 | |
HMY | (1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy- 3-methoxy-8-methyl-8,9,13,14,15,15a- hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine- 6,12(1aH)-dione | A,B | 3C9W | 0.73 | |
EED | (9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)- 11-(METHOXYMETHYL)ESTRA-1(10),2,4- TRIENE-3,17-DIOL | A,B | 2QGT | 0.77 | |
DXB | 1,2-HYDRO-1-OXY-3,4-HYDRO-3-(1- METHOXY-2-OXY-3,4-DIHYDROXYPENTYL)- 8,9-DIHYDROXY-7-METHYL-ANTHRACENE | A,B | 1BP8 | 0.73 | |
ERT | METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY- 7-METHOXY-6,11-DIOXO-4-{[2,3,6- TRIDEOXY-3-(DIMETHYLAMINO)-BETA- D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H- TETRACENE-1-CARBOXYLATE | A,B | 1TW2 | 0.72 | |
ERT | METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY- 7-METHOXY-6,11-DIOXO-4-{[2,3,6- TRIDEOXY-3-(DIMETHYLAMINO)-BETA- D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H- TETRACENE-1-CARBOXYLATE | A,B | 1TW3 | 0.72 | |
7CA | 5,7-DIHYDROXY-2-(4-METHOXYPHENYL)- 8-(3-METHYLBUTYL)-4-OXO-4H-CHROMEN- 3-YL 6-DEOXY-ALPHA-L-MANNOPYRANOSIDE | A | 2H44 | 0.77 | |
DM9 | N-HYDROXYMETHYL-N-(2-METHOXYETHYL)- DAUNOMYCIN | A | 482D | 0.71 | |
STG | ESTRIOL 3-(B-D-GLUCURONIDE) | H | 2BFV | 0.93 | |
STG | ESTRIOL 3-(B-D-GLUCURONIDE) | H,L | 1BFV | 0.93 | |
OFF | 2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]- L-THREO-PENTARIC ACID | A | 2OFF | 0.74 | |
MUF | (8alpha,10alpha,13alpha,17beta)- 17-[(4-hydroxyphenyl)carbonyl]androsta- 3,5-diene-3-carboxylic acid | A,B | 3BEJ | 0.73 | |
NOM | 7-HYDROXY-5-METHYL-3,3A,5,11B-TETRAHYDRO- 1,4-DIOXA-CYCLOPENTA[A]ANTHRACENE- 2,6,11-TRIONE | A | 1N5V | 0.72 | |
GGT | Trioxacarcin A | A,B | 3C2J | 0.72 | |
ODE | DIETHYL (1R,2S,3R,4S)-5,6-BIS(4- HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT- 5-ENE-2,3-DICARBOXYLATE | A,B | 2QH6 | 0.74 | |
ECS | 2,3,17BETA-TRIHYDROXY-1,3,5(10)- ESTRATRIENE | A,B,C,D | 2BW7 | 0.73 | |
MAX | MATAIRESINOL | A | 2BGM | 0.7 | |
HE7 | 4-{[(14beta,17alpha)-3-hydroxyestra- 1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid | A,B,C,D | 2Z77 | 0.81 | |
CRH | 1,2-HYDRO-1-OXY-3,4-HYDRO-3-(1- METHOXY-2-OXY-3,4-DIHYDROXYPENTYL)- 8,9-DIHYROXY-7-METHYLANTHRACENE | A,B | 146D | 0.73 | |
CRH | 1,2-HYDRO-1-OXY-3,4-HYDRO-3-(1- METHOXY-2-OXY-3,4-DIHYDROXYPENTYL)- 8,9-DIHYROXY-7-METHYLANTHRACENE | A,B | 207D | 0.73 | |
NCS | B | 1KVH | 0.7 | ||
NCS | A | 2NEO | 0.7 | ||
FRR | (3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY- 14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO- 1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)- DIONE | A | 2E14 | 0.71 | |
AOE | N-BUTYL-11-[(7R,8R,9S,13S,14S,17S)- 3,17-DIHYDROXY-13-METHYL-7,8,9,11,12,13,14,15,16,17- DECAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN- 7-YL]-N-METHYLUNDECANAMIDE | A | 1HJ1 | 0.7 | |
RUT | RUTIN | A,B | 1RY8 | 0.73 | |
SDT | 3,4-dihydroxy-9,10-secoandrosta- 1(10),2,4-triene-9,17-dione | A,B | 2ZI8 | 0.71 | |
CA2 | (1S,3R,4R,5S)-1,3,4-TRIHYDROXY- 5-(3-PHENOXYPROPYL)CYCLOHEXANECARBOXYLIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 2BT4 | 0.72 | |
AKY | A,B,C,D | 2IPI | 0.74 | ||
S1A | SORAPHEN A | A,B | 3GID | 0.76 | |
S1A | SORAPHEN A | A,B,C | 1W96 | 0.76 | |
POD | 9-HYDROXY-5-(3,4,5-TRIMETHOXYPHENYL)- 5,8,8A,9-TETRAHYDROFURO[3',4':6,7]NAPHTHO[2,3- D][1,3]DIOXOL-6(5AH)-ONE | A,B,C,D | 1SA1 | 0.77 | |
DM3 | 6-DEOXYDAUNOMYCIN | A | 1D14 | 0.72 | |
DM2 | DOXORUBICIN | A | 2DR6 | 0.72 | |
DM2 | DOXORUBICIN | A | 1P20 | 0.72 | |
DM2 | DOXORUBICIN | A | 1I1E | 0.72 | |
DM2 | DOXORUBICIN | A | 151D | 0.72 | |
DM2 | DOXORUBICIN | A | 1D12 | 0.72 | |
DM2 | DOXORUBICIN | A | 1DA9 | 0.72 | |
AKT | 10-DECARBOXYMETHYLACLACINOMYCIN T (DCMAT) | A | 1Q0R | 0.73 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1D15 | 0.72 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1D54 | 0.72 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1D58 | 0.72 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1QDA | 0.72 | |
AKA | 10-DECARBOXYMETHYLACLACINOMYCIN A (DCMAA) | A | 1Q0Z | 0.73 | |
SDN | [(3S)-9-hydroxy-1-methyl-10-oxo- 4,10-dihydro-3H-benzo[g]isochromen- 3-yl]acetic acid | A,B | 3B6C | 0.7 | |
44D | 7-[5-(4-AMINO-5-HYDROXY-6-METHYL- TETRAHYDRO-PYRAN-2-YLOXY)-4-HYDROXY- 6-METHYL-TETRAHYDRO-PYRAN-2-YLOXY]- 6,9,11-TRIHYDROXY-9-(2-HYDROXY- ACETYL)-7,8,9,10-TETRAHYDRO-NAPHTHACENE- 5,12-DIONE | A,B | 1NAB | 0.72 | |
CPH | 1,8-DIHYDROXY-7-METHYL-3-(1,3,4- TRIHYDROXY-2-OXO-PENTYL)-3,10-DIHYDRO- 2H-ANTHRACEN-9-ONE | A,B | 1D83 | 0.73 | |
CPH | 1,8-DIHYDROXY-7-METHYL-3-(1,3,4- TRIHYDROXY-2-OXO-PENTYL)-3,10-DIHYDRO- 2H-ANTHRACEN-9-ONE | A,B | 1EKH | 0.73 | |
CPH | 1,8-DIHYDROXY-7-METHYL-3-(1,3,4- TRIHYDROXY-2-OXO-PENTYL)-3,10-DIHYDRO- 2H-ANTHRACEN-9-ONE | A,B | 1EKI | 0.73 | |
CPH | 1,8-DIHYDROXY-7-METHYL-3-(1,3,4- TRIHYDROXY-2-OXO-PENTYL)-3,10-DIHYDRO- 2H-ANTHRACEN-9-ONE | A,B,C,D | 1VAQ | 0.73 | |
DM1 | DAUNOMYCIN | A | 152D | 0.72 | |
DM1 | DAUNOMYCIN | A,B,C,D | 1O0K | 0.72 | |
DM1 | DAUNOMYCIN | A | 1JO2 | 0.72 | |
DM1 | DAUNOMYCIN | A,B | 308D | 0.72 | |
DM1 | DAUNOMYCIN | A | 1D33 | 0.72 | |
DM1 | DAUNOMYCIN | A | 110D | 0.72 | |
DM1 | DAUNOMYCIN | A | 1D11 | 0.72 | |
DM1 | DAUNOMYCIN | A | 427D | 0.72 | |
DM1 | DAUNOMYCIN | A | 2D34 | 0.72 | |
DM1 | DAUNOMYCIN | A | 3F8F | 0.72 | |
DM1 | DAUNOMYCIN | A | 1D10 | 0.72 | |
DM1 | DAUNOMYCIN | A | 1DA0 | 0.72 | |
DM5 | IDARUBICIN | A,B,D | 198D | 0.73 | |
DM5 | IDARUBICIN | A | 1D38 | 0.73 | |
DM5 | IDARUBICIN | A | 1D67 | 0.73 | |
DZN | DAIDZIN | A,B,C,D,E,F, G,H | 2VLE | 0.73 | |
ECO | ESTRADIOL-6 CARBOXYL-METHYL-OXIME | B,D,F,H | 1JNH | 0.75 |